Complete Filing Data
Galera Therapeutics, Inc. reported Stockholders Equity of $3.97 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Galera Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | $149.0M | -$19.0M | -$59.1M | -$62.2M | -$80.5M | -$74.2M | -$51.9M | -$23.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $22.0K | -$8.0K | -$26.0K | -$26.0K | $35.0K | $6.0K | |
| Research And Development Expense | $349.0K | $3.2M | $24.1M | $31.0M | $52.4M | $54.8M | $42.3M | $18.7M |
| Operating Income Loss | -$2.5M | -$20.2M | -$49.3M | -$51.2M | -$73.4M | -$70.6M | -$50.7M | -$24.3M |
| General And Administrative Expense | $5.7M | $11.0M | $22.8M | $20.2M | $21.0M | $15.7M | $8.4M | $5.6M |
| Comprehensive Income Net Of Tax | -$19.0M | -$59.1M | -$62.2M | -$80.6M | -$74.2M | -$51.9M | -$23.7M | |
| Interest Expense | $0.00 | $11.4M | $11.6M | $7.2M | $4.9M | $3.0M | $220.0K | |
| Net Income Loss Available To Common Stockholders Basic | $63.5M | -$18.7M | -$59.1M | -$74.2M | -$59.1M | -$29.6M | ||
| Income Tax Expense Benefit | $0.00 | -$203.0K | $0.00 | $70.0K | $0.00 | -$16.0K | -$9.0K | -$223.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $149.0M | -$19.2M | -$59.1M | -$62.3M | -$80.5M | -$74.2M | -$51.9M | -$23.9M |
| Income Loss From Continuing Operations Per Diluted Share | -$1.33 | -$2.30 | -$3.12 | |||||
| Income Loss From Continuing Operations Per Basic Share | -$1.33 | -$2.30 | -$3.12 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.4M | -$1.1M | -$1.6M | -$5.6M | -$4.1M | -$4.4M | -$15.1M | -$20.7M | -$17.7M | -$16.0M | -$14.6M | -$15.4M | -$22.6M | -$22.4M | -$18.7M | -$17.1M | -$18.7M | -$18.4M | -$13.4M | -$11.6M | -$10.3M | -$5.2M | -$4.3M | -$5.5M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | -$5.0K | -$11.0K | $38.0K | $17.0K | -$49.0K | -$47.0K | -$5.0K | -$7.0K | -$2.0K | -$193.0K | -$370.0K | $648.0K | -$26.0K | $68.0K | $10.0K | $3.0K | |||||
| Research And Development Expense | $130.0K | $84.0K | $93.0K | $305.0K | $1.4M | $1.5M | $6.1M | $7.6M | $7.3M | $8.1M | $6.6M | $8.1M | $14.8M | $16.0M | $12.4M | $12.1M | $13.8M | $14.3M | $11.0M | $9.5M | $8.5M | $4.2M | ||
| Operating Income Loss | -$1.4M | -$1.1M | -$2.0M | -$5.9M | -$4.2M | -$4.6M | -$13.4M | -$16.8M | -$13.9M | -$13.0M | -$11.9M | -$13.2M | -$20.3M | -$21.1M | -$17.5M | -$16.1M | -$17.7M | -$17.8M | -$12.9M | -$11.3M | -$10.4M | -$5.4M | ||
| General And Administrative Expense | $1.3M | $1.1M | $1.9M | $3.4M | $2.8M | $3.1M | $5.0M | $9.2M | $6.6M | $4.9M | $5.3M | $5.0M | $5.5M | $5.1M | $5.1M | $3.9M | $3.9M | $3.6M | $1.8M | $1.8M | $1.9M | $1.2M | ||
| Comprehensive Income Net Of Tax | -$5.6M | -$4.1M | -$4.4M | -$15.1M | -$20.7M | -$17.7M | -$16.0M | -$14.6M | -$15.5M | -$22.6M | -$22.4M | -$18.7M | -$17.3M | -$19.0M | -$17.8M | -$13.4M | -$11.5M | -$10.3M | -$5.2M | |||||
| Interest Expense | $0.00 | $0.00 | $0.00 | $2.1M | $4.4M | $4.2M | $3.2M | $2.7M | $2.3M | $2.3M | $1.3M | $1.3M | $1.2M | $1.3M | $1.1M | $918.0K | $736.0K | $439.0K | ||||||
| Net Income Loss Available To Common Stockholders Basic | -$628.0K | -$486.0K | -$720.0K | -$5.6M | -$4.1M | -$4.4M | -$17.1M | -$18.7M | -$18.4M | -$15.5M | -$13.6M | -$12.4M | -$6.7M | |||||||||||
| Income Tax Expense Benefit | $0.00 | -$203.0K | $0.00 | -$52.0K | ||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.4M | -$5.8M | -$15.1M | -$13.4M | -$5.3M | |||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | ||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $4.0M | -$148.0M | -$131.2M | -$109.2M | -$58.0M | $6.1M | $69.6M | -$104.8M | -$76.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.4M | $8.3M | $18.3M | $4.3M | $19.9M | $15.9M | $18.4M | $14.8M | $6.2M |
| Accrued Liabilities Current | $380.0K | $391.0K | $3.4M | $9.8M | $7.6M | $8.6M | $5.5M | $2.6M | |
| Royalty Guarantees Commitments Amount | $0.00 | $151.0M | $151.0M | $139.6M | $128.1M | $63.4M | $43.3M | $20.2M | |
| Retained Earnings Accumulated Deficit | -$307.3M | -$456.4M | -$437.4M | -$378.3M | -$316.1M | -$235.6M | -$161.4M | -$104.8M | |
| Prepaid Expense And Other Assets Current | $720.0K | $1.1M | $3.4M | $3.6M | $6.2M | $5.2M | $5.3M | $1.5M | |
| Other Assets Noncurrent | $101.0K | $100.0K | $90.0K | $1.9M | $2.0M | $1.5M | $918.0K | $497.0K | |
| Liabilities Current | $645.0K | $1.7M | $5.0M | $13.4M | $12.9M | $14.0M | $9.7M | $6.4M | |
| Liabilities And Stockholders Equity | $7.2M | $10.1M | $26.1M | $44.0M | $83.3M | $84.1M | $123.4M | $88.1M | |
| Liabilities | $645.0K | $153.8M | $157.3M | $153.2M | $141.3M | $78.0M | $53.8M | $27.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.9M | -$10.0M | $13.9M | -$15.5M | $4.0M | -$2.5M | $3.5M | $8.6M | |
| Cash And Cash Equivalents At Carrying Value | $6.4M | $8.3M | $18.3M | $4.3M | $19.9M | $15.9M | $18.4M | $14.8M | |
| Assets Current | $7.1M | $10.0M | $21.6M | $38.5M | $77.4M | $77.9M | $117.6M | $83.9M | |
| Assets | $7.2M | $10.1M | $26.1M | $44.0M | $83.3M | $84.1M | $123.4M | $88.1M | |
| Accounts Payable Current | $265.0K | $1.3M | $1.4M | $3.6M | $5.0M | $5.1M | $3.9M | $3.9M | |
| Common Stock Value | $75.0K | $75.0K | $54.0K | $28.0K | $26.0K | $25.0K | $25.0K | ||
| Additional Paid In Capital Common Stock | $311.2M | $308.2M | $306.2M | $269.1M | $258.1M | $241.6M | $230.9M | ||
| Property Plant And Equipment Net | $0.00 | $71.0K | $438.0K | $527.0K | $1.0M | $934.0K | $568.0K | ||
| Goodwill | $0.00 | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | ||
| Deferred Tax Liabilities Derivatives | $0.00 | $203.0K | $203.0K | $273.0K | $273.0K | $289.0K | $298.0K | ||
| Operating Lease Right Of Use Asset | $0.00 | $1.2M | $43.0K | $296.0K | $530.0K | $815.0K | |||
| Long Term Debt And Capital Lease Obligations Current | $0.00 | $133.0K | $44.0K | $258.0K | $238.0K | $297.0K | |||
| Operating Lease Liability Noncurrent | $0.00 | $1.1M | $0.00 | $44.0K | $296.0K | $534.0K | |||
| Short Term Investments | $0.00 | $27.3M | $51.4M | $56.9M | $93.9M | $66.7M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | -$22.0K | -$14.0K | $12.0K | $38.0K | $3.0K | |||
| Indefinite Lived Intangible Assets Excluding Goodwill | $0.00 | $2.3M | $2.3M | $2.3M | $2.3M | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | ||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$48.0K | $72.0K | $0.00 | |||||
| Finite Lived Intangible Assets Net | $2.3M | $2.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$149.2M | -$147.9M | -$147.2M | -$143.1M | -$138.0M | -$134.7M | -$126.6M | -$115.0M | -$97.6M | -$97.5M | -$83.2M | -$70.5M | -$43.2M | -$25.5M | -$10.6M | $24.7M | $40.2M | $53.1M | -$144.6M | -$129.7M | -$116.7M | -$94.4M | -$87.9M | -$82.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.5M | $5.2M | $6.7M | $8.5M | $10.7M | $13.5M | $24.4M | $24.4M | $25.7M | $12.8M | $17.4M | $19.6M | $17.6M | $38.5M | $13.7M | $15.2M | $15.9M | $21.6M | $15.7M | $16.2M | $8.5M | $53.0M | ||||
| Accrued Liabilities Current | $164.0K | $145.0K | $231.0K | $618.0K | $1.2M | $831.0K | $8.8M | $8.0M | $7.3M | $7.3M | $7.2M | $6.6M | $8.3M | $8.3M | $6.3M | $6.2M | $5.4M | $5.7M | $3.6M | |||||||
| Royalty Guarantees Commitments Amount | $151.0M | $151.0M | $151.0M | $151.0M | $151.0M | $151.0M | $150.3M | $148.3M | $143.9M | $136.3M | $133.1M | $130.4M | $125.8M | $123.4M | $64.6M | $62.1M | $60.9M | $64.3M | $42.3M | |||||||
| Retained Earnings Accumulated Deficit | -$460.4M | -$459.0M | -$458.0M | -$451.4M | -$445.9M | -$441.8M | -$431.8M | -$416.7M | -$396.0M | -$362.1M | -$346.1M | -$331.5M | -$299.3M | -$276.7M | -$254.3M | -$215.5M | -$198.4M | -$179.8M | -$144.7M | |||||||
| Prepaid Expense And Other Assets Current | $428.0K | $717.0K | $874.0K | $444.0K | $1.2M | $1.7M | $2.8M | $3.2M | $3.2M | $2.1M | $3.2M | $4.3M | $4.0M | $4.8M | $6.7M | $3.2M | $4.0M | $4.5M | $4.2M | |||||||
| Other Assets Noncurrent | $101.0K | $101.0K | $101.0K | $2.0K | $90.0K | $90.0K | $1.9M | $1.6M | $1.9M | $2.1M | $2.1M | $1.9M | $1.6M | $1.8M | $1.5M | $956.0K | $918.0K | $1.0M | $528.0K | |||||||
| Liabilities Current | $598.0K | $347.0K | $975.0K | $914.0K | $2.1M | $2.0M | $12.6M | $13.6M | $13.3M | $11.6M | $11.0M | $10.9M | $15.7M | $16.8M | $15.9M | $10.5M | $12.4M | $12.6M | $9.1M | |||||||
| Liabilities And Stockholders Equity | $5.0M | $6.0M | $7.7M | $8.9M | $16.4M | $19.7M | $37.8M | $48.3M | $59.7M | $50.7M | $61.1M | $71.1M | $98.8M | $115.3M | $70.5M | $98.1M | $114.3M | $130.8M | $79.8M | |||||||
| Liabilities | $151.6M | $151.4M | $152.0M | $152.0M | $154.4M | $154.3M | $164.3M | $163.3M | $157.3M | $148.2M | $144.3M | $141.6M | $141.9M | $140.8M | $81.1M | $73.4M | $74.1M | $77.8M | $52.3M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.6M | -$4.8M | $21.4M | -$214.0K | -$2.2M | $3.2M | -$6.3M | |||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $4.5M | $5.2M | $6.7M | $8.5M | $10.7M | $13.5M | $24.4M | $24.3M | $25.7M | $12.7M | $17.4M | $19.6M | $17.6M | $38.5M | $13.7M | $15.2M | $15.9M | $21.6M | $15.7M | |||||||
| Assets Current | $4.9M | $5.9M | $7.6M | $8.9M | $12.0M | $15.2M | $31.2M | $42.0M | $54.2M | $44.9M | $55.2M | $65.3M | $92.7M | $108.9M | $64.2M | $92.3M | $108.4M | $125.0M | $72.1M | |||||||
| Assets | $5.0M | $6.0M | $7.7M | $8.9M | $16.4M | $19.7M | $37.8M | $48.3M | $59.7M | $50.7M | $61.1M | $71.1M | $98.8M | $115.3M | $70.5M | $98.1M | $114.3M | $130.8M | $79.8M | |||||||
| Accounts Payable Current | $434.0K | $202.0K | $744.0K | $296.0K | $812.0K | $1.0M | $3.7M | $5.5M | $5.9M | $3.6M | $3.6M | $4.1M | $7.2M | $8.3M | $9.2M | $4.0M | $6.8M | $6.6M | $5.2M | |||||||
| Common Stock Value | $75.0K | $75.0K | $75.0K | $54.0K | $54.0K | $54.0K | $54.0K | $44.0K | $43.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | $25.0K | $25.0K | $25.0K | $25.0K | ||||||||
| Additional Paid In Capital Common Stock | $311.1M | $311.0M | $310.7M | $308.3M | $307.8M | $307.0M | $305.2M | $301.7M | $298.4M | $264.7M | $262.9M | $261.1M | $256.1M | $251.1M | $243.7M | $240.0M | $238.3M | $232.1M | ||||||||
| Property Plant And Equipment Net | $0.00 | $56.0K | $62.0K | $198.0K | $210.0K | $418.0K | $464.0K | $486.0K | $509.0K | $938.0K | $1.0M | $1.1M | $1.1M | $1.2M | $892.0K | $970.0K | ||||||||||
| Goodwill | $0.00 | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | $881.0K | ||||||||||
| Deferred Tax Liabilities Derivatives | $0.00 | $203.0K | $203.0K | $203.0K | $203.0K | $203.0K | $273.0K | $273.0K | $273.0K | $273.0K | $273.0K | $273.0K | $289.0K | $289.0K | $289.0K | $298.0K | ||||||||||
| Operating Lease Right Of Use Asset | $0.00 | $1.1M | $1.2M | $1.2M | $1.3M | $0.00 | $106.0K | $168.0K | $229.0K | $374.0K | $450.0K | $526.0K | $603.0K | $675.0K | $745.0K | $876.0K | ||||||||||
| Long Term Debt And Capital Lease Obligations Current | $0.00 | $157.0K | $136.0K | $131.0K | $128.0K | $0.00 | $109.0K | $172.0K | $234.0K | $271.0K | $284.0K | $296.0K | $250.0K | $268.0K | $285.0K | $291.0K | ||||||||||
| Operating Lease Liability Noncurrent | $0.00 | $1.0M | $1.1M | $1.2M | $1.2M | $0.00 | $110.0K | $172.0K | $235.0K | $356.0K | $414.0K | $472.0K | $604.0K | |||||||||||||
| Short Term Investments | $4.0M | $14.5M | $22.1M | $30.0M | $34.6M | $41.3M | $71.1M | $28.1M | $43.8M | $73.9M | $88.5M | $98.9M | $52.2M | |||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | $5.0K | $16.0K | -$93.0K | -$110.0K | -$61.0K | -$2.0K | $3.0K | $10.0K | $123.0K | $316.0K | $686.0K | $55.0K | |||||||||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | $0.00 | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | ||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | ||||||||||||||||||||||||||
| Finite Lived Intangible Assets Net | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $410.0K | $2.5M | $5.6M | $7.2M | $7.2M | $5.5M | $2.4M | $865.0K |
| Net Cash Provided By Used In Operating Activities | -$6.0M | -$12.1M | -$44.8M | -$43.4M | -$68.0M | -$59.5M | -$46.7M | -$22.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$357.0K | -$2.3M | -$514.0K | -$2.5M | $1.0M | -$127.0K | $3.8M | $986.0K |
| Increase Decrease In Other Noncurrent Assets | $1.0K | -$89.0K | -$1.9M | -$330.0K | $246.0K | $274.0K | $421.0K | $255.0K |
| Increase Decrease In Accounts Payable | -$1.0M | -$1.4M | -$2.2M | -$1.5M | -$101.0K | $1.2M | $77.0K | $1.6M |
| Net Cash Provided By Used In Financing Activities | $635.0K | $2.2M | $31.5M | $3.9M | $66.7M | $20.5M | $78.0M | $89.8M |
| Net Cash Provided By Used In Investing Activities | $3.5M | -$46.0K | $27.3M | $24.0M | $5.2M | $36.5M | -$27.8M | -$59.0M |
| Proceeds From Sale Of Short Term Investments | $0.00 | $50.0M | $83.9M | $77.5M | $104.8M | $96.0M | $12.5M | |
| Payments To Acquire Short Term Investments | $0.00 | $22.6M | $59.9M | $72.0M | $67.7M | $123.2M | $71.2M | |
| Payments To Acquire Property Plant And Equipment | $0.00 | $59.0K | $25.0K | $283.0K | $457.0K | $633.0K | $347.0K | |
| Increase Decrease In Accrued Liabilities | -$11.0K | -$3.1M | -$6.3M | $2.1M | -$951.0K | $2.9M | $2.9M | $540.0K |
| Proceeds From Stock Options Exercised | $0.00 | $188.0K | $81.0K | $1.3M | $506.0K | $10.0K | ||
| Increase Decrease In Other Operating Capital Net | $0.00 | $38.0K | $104.0K | $258.0K | $307.0K | $0.00 | ||
| Depreciation Depletion And Amortization | $0.00 | $20.0K | $259.0K | $114.0K | $778.0K | $368.0K | ||
| Proceeds From Royalty Purchase Agreement | $0.00 | $57.5M | $20.0M | $20.0M | $20.0M | |||
| Proceeds From Sale Of Common Stock And Common Stock Warrants In Registered Direct Offering | $0.00 | $27.6M | $0.00 | |||||
| Proceeds From Issuance Initial Public Offering | $1.7M | $3.8M | $7.9M | $0.00 | $58.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $137.0K | $875.0K | $1.5M | $1.8M | $1.8M | $1.2M | $499.0K |
| Net Cash Provided By Used In Operating Activities | -$2.2M | -$4.8M | -$11.7M | -$11.4M | -$15.3M | -$12.4M | -$8.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$203.0K | -$1.7M | -$446.0K | -$1.8M | $1.6M | -$780.0K | $1.1M |
| Increase Decrease In Other Noncurrent Assets | $1.0K | -$38.0K | -$10.0K | -$78.0K | -$4.0K | $31.0K | $2.0K |
| Increase Decrease In Accounts Payable | -$531.0K | -$329.0K | $2.4M | -$913.0K | $4.1M | $2.7M | $261.0K |
| Net Cash Provided By Used In Financing Activities | $635.0K | $0.00 | $27.8M | $1.2M | $235.0K | $20.0M | |
| Net Cash Provided By Used In Investing Activities | $0.00 | $5.3M | $10.0M | $12.9M | -$4.4M | $2.6M | |
| Proceeds From Sale Of Short Term Investments | $0.00 | $17.8M | $25.7M | $20.0M | $16.8M | $15.1M | |
| Payments To Acquire Short Term Investments | $0.00 | $12.4M | $15.7M | $6.9M | $21.1M | $12.2M | |
| Payments To Acquire Property Plant And Equipment | $0.00 | $13.0K | $186.0K | $38.0K | $303.0K | ||
| Increase Decrease In Accrued Liabilities | -$160.0K | -$2.6M | -$2.4M | -$1.1M | -$2.2M | ||
| Proceeds From Stock Options Exercised | $0.00 | $184.0K | $58.0K | $235.0K | $9.0K | ||
| Increase Decrease In Other Operating Capital Net | $0.00 | $37.0K | $44.0K | $68.0K | $3.0K | ||
| Depreciation Depletion And Amortization | $0.00 | $9.0K | $20.0K | $31.0K | $106.0K | ||
| Proceeds From Royalty Purchase Agreement | $20.0M | ||||||
| Proceeds From Sale Of Common Stock And Common Stock Warrants In Registered Direct Offering | $635.0K | $0.00 | $27.6M | ||||
| Proceeds From Issuance Initial Public Offering | $27.6M | $1.1M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.64 | -$0.34 | -$1.33 | -$3.12 | -$2.98 | -$16.31 | -$98.42 | |
| Common Stock Shares Outstanding | 75.5M | 75.5M | 54.4M | 28.5M | 26.5M | 25.0M | 24.8M | 300.6K |
| Preferred Stock Shares Outstanding | 119.3K | 119.3K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 119.3K | 119.3K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Issued | 75.5M | 75.5M | 54.4M | 28.5M | 26.5M | 25.0M | 25.0M | 300.6K |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 98.5M | 54.6M | 44.5M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 98.5M | 54.6M | 44.5M | |||||
| Earnings Per Share Basic | $0.64 | $-0.34 | $-1.33 | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 25.8M | 24.9M | 3.6M | 300.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.01 | $0.00 | -$0.01 | -$0.10 | -$0.07 | -$0.08 | -$0.33 | -$0.48 | -$0.50 | -$0.60 | -$0.54 | -$0.58 | -$0.86 | -$0.88 | -$0.75 | -$0.69 | -$0.75 | -$0.74 | -$51.43 | -$45.30 | -$41.12 | -$22.35 |
| Common Stock Shares Outstanding | 75.5M | 75.5M | 75.5M | 54.4M | 54.4M | 54.4M | 53.7M | 43.8M | 42.9M | 26.8M | 26.8M | 26.8M | 26.4M | 25.9M | 25.2M | 24.9M | 24.8M | 24.8M | 300.6K | |||
| Preferred Stock Shares Outstanding | 119.3K | 119.3K | 119.3K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 119.3K | 119.3K | 119.3K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Issued | 75.5M | 75.5M | 75.5M | 54.4M | 54.4M | 54.4M | 53.7M | 43.8M | 42.9M | 26.8M | 26.8M | 26.8M | 26.4M | 25.2M | 24.9M | 24.8M | 24.8M | 300.6K | ||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 98.5M | 98.5M | 98.5M | 54.4M | 54.4M | 54.4M | 45.5M | 42.9M | 35.2M | 26.8M | 26.8M | 26.7M | 26.3M | 25.4M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 98.5M | 98.5M | 98.5M | 54.4M | 54.4M | 54.4M | 45.5M | 42.9M | 35.2M | 26.8M | 26.8M | 26.7M | 26.3M | 25.4M | ||||||||
| Earnings Per Share Basic | $-0.01 | $0.00 | $-0.01 | $-0.10 | $-0.07 | $-0.08 | $-0.33 | $-0.48 | $-0.50 | $-0.60 | $-0.54 | $-0.58 | $-0.86 | $-0.88 | ||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 26.7M | 26.3M | 25.4M | 25.0M | 24.9M | 24.8M | 24.8M | 300.6K | 300.6K | 300.6K | 300.6K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $410.0K | $2.5M | $5.6M | $7.2M | $7.2M | $5.5M | $2.4M | $865.0K |
| Investment Income Interest | $248.0K | $554.0K | $1.6M | $506.0K | $32.0K | $1.2M | $1.8M | $606.0K |
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | -$6.0K | -$3.0K | -$1.0K | -$4.0K | $25.0K | -$40.0K | -$30.0K |
| Stock Issued During Period Value Stock Options Exercised | $188.0K | $81.0K | $1.3M | $506.0K | $10.0K | |||
| Paid In Kind Interest | $0.00 | $11.4M | $11.6M | $7.2M | $4.9M | $3.0M | $220.0K | |
| Sale Of Shares Under Open Market Sale Agrrement | 1.7M | 3.8M | -7.9M | |||||
| Stock Issued During Period Shares Stock Options Exercised | 23.0M | 78.6K | 68.5K | 591.3K | 164.6K | 3.8K | ||
| Depreciation | $368.0K | $267.0K | $127.0K | |||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $9.0K | $0.00 | $23.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $91.0K | $90.0K | $137.0K | $551.0K | $723.0K | $875.0K | $1.4M | $1.5M | $1.5M | $1.8M | $1.8M | $1.8M | $1.9M | $1.6M | $1.8M | $1.5M | $1.5M | $1.2M | $520.0K | $565.0K | $499.0K | $220.0K | $226.0K | $208.0K |
| Investment Income Interest | $48.0K | $60.0K | $77.0K | $126.0K | $149.0K | $196.0K | $411.0K | $494.0K | $395.0K | $171.0K | $71.0K | $14.0K | $3.0K | $6.0K | $19.0K | $235.0K | $352.0K | $468.0K | $426.0K | $513.0K | $457.0K | $117.0K | ||
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | $0.00 | -$2.0K | -$4.0K | $0.00 | -$1.0K | $0.00 | -$1.0K | -$1.0K | -$1.0K | $0.00 | -$2.0K | -$2.0K | -$1.0K | $28.0K | -$3.0K | -$64.0K | $29.0K | -$11.0K | |||||
| Stock Issued During Period Value Stock Options Exercised | $4.0K | $184.0K | $10.0K | $2.0K | $58.0K | $890.0K | $120.0K | $235.0K | $224.0K | $41.0K | $9.0K | |||||||||||||
| Paid In Kind Interest | $0.00 | $4.2M | $2.3M | $1.3M | $1.1M | $439.0K | ||||||||||||||||||
| Sale Of Shares Under Open Market Sale Agrrement | -1.9M | -27.6M | 1.1M | 2.2M | -5.7M | |||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 76.8K | 46.4K | 217.0K | 8.5K | ||||||||||||||||||||
| Depreciation | $106.0K | $80.0K | $46.0K | |||||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid |
Most recent annual filing with the SEC: March 19, 2026
Data sourced from SEC EDGAR public filings as of August 9, 2026.